Debrief Overview
In this session, you’ll hear what Leading Health System Pharmacy leaders discussed during our fall in-person gatherings with their peers—and we’ll share our perspective on the key themes and what they mean for industry organizations that work with them.
Major Themes
340B, IRA & Policy Crosswinds - Health systems are navigating mounting 340B and policy uncertainty as manufacturers shift toward rebate-based models and federal rulemaking accelerates. CPOs are urged to align with advocacy and government affairs teams, reinforce patient access narratives, and plan for financial and operational volatility.
Sites of Care Shift: Ambulatory & Home Infusion - Health systems are accelerating shifts toward ambulatory and home infusion care, driven by payer policies and site-neutral reimbursement. Success depends on market-tailored strategies, integrated oncology-pharmacy models, and partnerships that expand access while managing operational and compliance complexity.
AI in Pharmacy: From Pilots to Enterprise Value - Pharmacy leaders are moving beyond AI pilots toward enterprise value, starting with automation in prior authorization that boosts efficiency and reduces denials. Success hinges on co-developing tools with industry partners, expanding use cases across operations, and pairing data-driven results with strong governance and storytelling to sustain leadership buy-in.
Pharmacy’s Strategic Seat at the Table - Pharmacy is emerging as a strategic pillar in health system growth and population health, with CFOs increasingly engaged in drug and specialty pharmacy strategy. As pharmacists take on more provider-like roles, inclusive governance and workforce upskilling are key to aligning innovation with clinical excellence.